WHO passes a Bangladesh-pushed resolution on autism
The World Health Assembly of World Health Organisation (WHO) passed a Bangladesh-pushed resolution on autism in Geneva. Health and Family […]
Say something
The World Health Assembly of World Health Organisation (WHO) passed a Bangladesh-pushed resolution on autism in Geneva. Health and Family […]
Rohit Kumar, Managing Director-South Asia, Elsevier Health Sciences eLearning is not new in India; in fact,today it has become quite […]
GE Healthcare today announced the signing of a new agreement with Sigma-Aldrich to distribute its Whatman range of products in […]
The BVS is made of polylactide, a naturally dissolvable material that is commonly used in medical implants such as dissolving sutures […]
Trivitron Healthcare (Medical Technology Solutions provider) has entered into a partnership with Johari Digital Healthcare to market physiotherapy products, point […]
Wipro GE Healthcare, GE Healthcare’s business arm in India received the FICCI (Federation of Indian Chambers of Commerce and Industry) […]
The US has sought to impress upon India to lift the ban on American poultry products, arguing that they do […]
India has pitched for greater collaboration among South Asian countries in addressing health problems. Inaugurating the 4th Regional Meeting of […]
Dr GSK Velu Managing Director Company name: Trivitron Group of Companies Corporate Headquarters No. 15, IV Street, Abhiramapuram, Chennai – […]
A latest study by the Harvard School of Public Health has found that while the South-East Asia region has just 2.6 OTs per one lakh population, the number is as low as 1.3 OT per 1 lakh population in India and Pakistan.
Annual India Excellence in Healthcare Awards to Celebrate Best in Industry.
In a bid to help combat Malaria and other fatal diseases in India, World Bank has announced a USD 520 million scheme, the largest such project by the world body in any country.
The World Bank has declared two India-based firms, Nestor Pharmaceuticals Ltd. (Nestor) and Pure Pharma Ltd. (Pure Pharma), ineligible to be awarded Bank-financed contracts.